VIPoma causes are mostly sporadic pancreatic neuroendocrine tumors, though MEN1 syndrome plays a role. Learn the locations, pathophysiology, and symptoms.
VIPoma causes come down to one thing: a rare neuroendocrine tumor that releases far too much vasoactive intestinal peptide (VIP). About 90% of these tumors begin in the pancreas, and most are sporadic, meaning they appear with no inherited gene mutation and no family history. Roughly 5% to 15% instead occur in people who carry a MEN1 mutation.
What Actually Causes a VIPoma?
A VIPoma is not caused by diet, stress, smoking, or any other lifestyle factor. It forms when neuroendocrine cells — cells that behave like both nerve cells and hormone-producing cells — start dividing abnormally and dump VIP into the bloodstream.
The recognized causes and associations are:
- Sporadic pancreatic neuroendocrine tumors (pNETs). The large majority of VIPomas fall here, with no family history and no identified inherited mutation.
- MEN1 syndrome. An inherited mutation in the MEN1 gene raises the risk of tumors in the pancreas, parathyroid glands, and pituitary. People with MEN1 tend to develop a VIPoma at a younger age than those with sporadic tumors.
- Other rare inherited syndromes. Neurofibromatosis type 1 and von Hippel-Lindau disease are linked to pancreatic neuroendocrine tumors, although VIPomas in these settings are uncommon.
- Extrapancreatic neurogenic tumors. In children, VIP can be produced by ganglioneuromas, ganglioneuroblastomas, or pheochromocytomas located outside the pancreas.
Because the underlying driver is a genetic or random cellular change, there is no known way to prevent a VIPoma from forming.
VIPoma Location: Where These Tumors Usually Appear
Location shapes both the symptoms and the surgical options. The pancreas is by far the most common site, and within the pancreas, the body and tail are involved more often than the head.
| Location | Share of cases | Notes |
|---|---|---|
| Pancreas — body or tail | About 60–70% of pancreatic VIPomas | Often larger when found; can be missed on early imaging |
| Pancreas — head | About 30–40% of pancreatic VIPomas | May block the bile duct and cause jaundice |
| Extrapancreatic sites (retroperitoneum, adrenal gland, mediastinum) | About 10–20% overall | More common in children, usually neurogenic in origin |
| Liver (metastatic disease at diagnosis) | Up to 60% of adults | Metastases are a complication, not the original site |
Roughly half of adults already have liver metastases when the tumor is first identified. That does not mean the tumor started in the liver — the primary tumor is almost always in the pancreas or, less often, another neuroendocrine site.
VIPoma Pathophysiology: How VIP Drives the Symptoms
VIP is a normal signaling molecule in the gut and nervous system. In healthy amounts, it relaxes smooth muscle, supports blood flow, and helps regulate intestinal secretion.
When a tumor releases large amounts of VIP, the peptide binds to VPAC1 and VPAC2 receptors on intestinal cells and raises intracellular cAMP. The result is a chain reaction:
- Intestinal cells pump water and electrolytes into the gut lumen, producing diarrhea that continues even when the patient fasts.
- Potassium is lost in the stool, leading to severe hypokalemia.
- VIP suppresses gastric acid secretion, causing achlorhydria, or low stomach acid.
- Bicarbonate is lost as well, which can produce a non-gap metabolic acidosis.
Together these features form WDHA syndrome — watery diarrhea, hypokalemia, and achlorhydria — also known as Verner-Morrison syndrome. Stool volumes commonly exceed 3 liters per day and can reach 10 liters, which makes dehydration and kidney injury genuine risks.
A VIP-secreting tumor is not an insulin-secreting tumor
Some people search for "VIP secreting tumor insulin" because both are pancreatic neuroendocrine tumors. They are separate diseases with separate hormones. A VIPoma releases VIP and causes chronic watery diarrhea with low potassium. An insulinoma releases insulin and causes hypoglycemia, with symptoms such as confusion, sweating, and fainting between meals.
What Else Can Look Like a VIPoma?
Chronic diarrhea has many causes, so doctors rule out other explanations before confirming a VIPoma. Mimics and look-alikes include:
- Laxative or diuretic abuse (sometimes called surreptitious laxative use)
- Gastrinoma (Zollinger-Ellison syndrome) and other neuroendocrine tumors
- Carcinoid syndrome, medullary thyroid carcinoma, and mastocytosis
- Celiac disease, microscopic colitis, and chronic infections such as giardiasis
- Villous adenoma of the colon, which can also cause secretory diarrhea with hypokalemia
A typical workup includes a serum VIP level, which is usually above 75 pg/mL in confirmed cases, plus stool volume and electrolytes, serum potassium and bicarbonate, and gastric acid studies. Imaging with CT, MRI, or endoscopic ultrasound helps locate the tumor, and Ga-68 DOTATATE PET can reveal additional sites of disease.
When to Seek Medical Care
Persistent watery diarrhea — particularly with weakness, muscle cramps, palpitations, or lightheadedness — deserves prompt medical evaluation. These symptoms can come from many conditions, and only testing can sort out the cause.
Treatment for a confirmed VIPoma typically combines surgery when the tumor can be removed, somatostatin analogs such as octreotide to reduce VIP output, and aggressive replacement of fluids and potassium. Anyone with these symptoms should talk with a healthcare professional rather than self-treat, and should ask about referral to an endocrinologist or a center experienced with neuroendocrine tumors.
Why Unrelated Peptide Pages Show Up in VIPoma Searches
Rare disease searches pull in a lot of unrelated results. Someone looking for endocrine information may land on pages about glutathione deficiency causes or where to buy bpc-157 peptide, even though those topics have nothing to do with pancreatic tumors.
Those results are not part of any recognized VIPoma evaluation or care. Questions such as does bpc-157 help with muscle growth come from laboratory and supplement research, not oncology, and searching is igf 1 lr3 safe belongs to that same separate category. For trustworthy information, use the National Cancer Institute, the NIH Genetic and Rare Diseases Information Center, and peer-reviewed endocrinology journals.
Frequently Asked Questions
What is the most common cause of a VIPoma?
Most VIPomas are sporadic pancreatic neuroendocrine tumors with no inherited cause and no family history. About 5% to 15% develop in people who carry a MEN1 gene mutation, and a small number arise from neurogenic tumors outside the pancreas, mostly in children.
Where is a VIPoma most commonly located?
The pancreas, especially the body and tail, is the most common VIPoma location. Roughly 10% to 20% of VIPomas are extrapancreatic and arise in sites such as the retroperitoneum, adrenal gland, or mediastinum.
Does a VIPoma secrete insulin?
No. A VIPoma secretes vasoactive intestinal peptide, which causes watery diarrhea, hypokalemia, and low stomach acid. Insulin is produced by an insulinoma, a different pancreatic neuroendocrine tumor that causes low blood sugar instead.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.